Thymic Carcinoma

American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma. https://t.co/5doAT5yDKI (@radioncoluis)

American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma | Cardiothoracic Surgery | JAMA Oncology | JAMA Network https://t.co/hUM2HHw3ac (@LujanPomponio)

Happy to announce the publication of our ARS thymic carcinoma manuscript in JAMA Oncology on line today. ARS AUC thoracic committee made another significant contribution to oncology community. See the link: https://t.co/hb0SDGCuhV (@JoeChangMD)

How should we deliver #radiotherapy for thymic cancer in the UK? Work presented at #ESTRO23 shows disparate Thymic carcinoma care. Real need to establish a Central UK Thymic Ca MDT (@gerryhanna)

Molecularly matched therapy (MMT) was given in 2009 :) This is my first MMT case-thymic carcinoma with C-KIT mutation . (@UmutDisel)

Avelumab/axitinib in B3 thymoma & thymic carcinoma (CAVEATT) N=32 (thymic carcinoma majority) ORR=34% Similar PFS between between PD-L1 high vs. PD-L1 low/negative is notable Incidence of serious irAEs=12% (similar to PD-1 monoTx) @TheLancetOncol https://t.co/LQL8ueEWJQ (@chulkimMD)

The purpose of this #meta-analysis is to characterize the association🔀 between PD-L1 expression and different stages of #thymoma 🆓🔗https://t.co/OJz3i5VnZh #thymiccarcinoma #rarecancer @Dr_Ivanoncologo @AbhijitSurgPath @smlungpathguy #pathology (@TumoriJ)

Targeting mTOR and CDK4/6 in #thymictumors ⁦@SukiPaddaMD⁩ thymoma versus thymic carcinoma diagnosis in autoimmune syndromes ⁦@gotoPER⁩ #ilc2021 with cochairs ⁦@HwakeleeMD⁩ ⁦@drgandara⁩ ⁦@DrRoyHerbstYale⁩ ⁦@CedarsSinai⁩ (@donnashort)